Recalls from Zydus Pharmaceuticals (USA) Inc

• Zydus Hydrocortisone Sodium Succinate for Injection (opens in a new tab)
  Moderate risk, FDA, Oct 13, 2026, Drug impurity
• Zydus Mirabegron Extended-Release Tablets (opens in a new tab)
  Moderate risk, FDA, Aug 6, 2026, Drug impurity
• Zydus Erythromycin Tablets (opens in a new tab)
  Moderate risk, FDA, May 20, 2026, Drug impurity
• Zydus Pharmaceuticals Icosapent Ethyl Capsules (opens in a new tab)
  Moderate risk, FDA, Mar 12, 2026, Quality testing problem
• Zydus Pharmaceuticals Icosapent Ethyl Capsules (opens in a new tab)
  Moderate risk, FDA, Jan 22, 2026, Wrong drug strength

Data: Recall Canary (opens in a new tab)